NASDAQ:CNTX | Free Cash Flow | Context Therapeutics Inc.

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2020-12-31 to 2026-03-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2026-03-31-$11.43M$37,258.00-$11.47M
2025-12-31-$8.94M$0.00-$8.94M
2025-03-31-$5.03M$33,948.00-$5.06M
2024-12-31-$4.91M$0.00-$4.91M
2024-03-31-$4.36M$0.00-$4.36M
2023-12-31-$7.23M$0.00-$7.23M
2023-03-31-$5.73M$0.00-$5.73M
2022-12-31-$3.93M$0.00-$3.93M
2022-03-31-$3.82M$34,999.00-$3.86M
2021-12-31-$4.96M$0.00-$4.96M
2021-03-31-$1.72M$0.00-$1.72M
2020-12-31-$176,025.00

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$26.39M$33,948.00-$26.42M
2024-12-31-$14.56M$7,316.00-$14.56M
2023-12-31-$21.05M$0.00-$21.05M
2022-12-31-$13.55M$36,836.00-$13.59M
2021-12-31-$8.8M$0.00-$8.8M
2020-12-31-$1.03M